Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 30 July 2009, doi:10.1136/bmj.b3088
Cite this as: BMJ 2009;339:b3088
Jane Smith, deputy editor
1 BMJ
jsmith@bmj.com
| The first 150 words of the full text of this article appear below. |
Transparency is a major theme in this weeks BMJ. Its explicit in Rosalind Smyths editorial on making information about clinical trials publicly available (doi:10.1136/bmj.b2473). She explains how trial registration in Europe has come through an unusual route, through regulations on testing drugs for use in children. These require all trials of paediatric drugs conducted in Europe to be made publicly available on the EudraCT database. There seemed no logic to insisting on information on trials in children but not in adults, so now the database will include protocols of all trials, with a requirement for results to be available too.
Perhaps surprisingly, transparency also emerges as an important element in improving the worlds supply of healthy food. In their article on the causes and effects of rising food prices Karen Lock and colleagues describe how agricultural subsidies favour high fat, energy dense foods at the expense of
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses